Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Armistice Capital, LLC reported a 5.21% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 5.21% stake in Agios Pharmaceuticals, Inc., 3,036,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.21%
- Shares
- 3,036,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 5.21% | 3,036,000 |
| Steven Boyd | 5.21% | 3,036,000 |
Source
Related
- Agios Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Agios Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026